lifestyle.newsblaze.com

Author: RatioTx/Russo Partners LLC

Ratio Therapeutics Appoints Global Medical Leader Colin Hayward as Chief Medical Officer

March 12, 2026
Ratio Therapeutics has Successfully Dosed the First Cohort in its Phase 1/2 Study Evaluating a Novel FAP-Targeted Radiopharmaceutical in Patients with Late-Stage Aggressive Sarcomas

December 17, 2025
Ratio Therapeutics Announces the Appointment of Marcel Reichen as Chief Strategy Officer

November 6, 2025